The impact of somatic and cognitive depressive symptoms on medical prognosis in patients with end-stage renal disease

Document Type

Journal Article

Publication Title

Perspectives in Psychiatric Care

Volume

58

Issue

1

First Page

297

Last Page

303

PubMed ID

33861469

Publisher

Wiley

School

School of Nursing and Midwifery

RAS ID

35625

Funders

The Deanship of Scientific Research - The University of Jordan

Comments

Khalil, A. A., Darawad, M. W., Abed, M. A., Hamdan‐Mansour, A., Arabiat, D. H., Alnajar, M. K., & Saleh, Z. T. (2022). The impact of somatic and cognitive depressive symptoms on medical prognosis in patients with end‐stage renal disease. Perspectives in Psychiatric Care, 58(1), 297-303.

https://doi.org/10.1111/ppc.12786

Abstract

Purpose:

To determine whether somatic or cognitive depressive symptoms affect hospitalization and death in patients with end-stage renal disease.

Design and Method:

In an observational retrospective design, the patients (n = 190) completed the Beck Depression Inventory-II at baseline and were followed for 5 years to collect data all-cause mortality and hospitalization.

Findings:

High somatic (53.7%, n = 102) and cognitive (52.1%, n = 99) depressive symptoms scores significantly associated with mortality (38% vs. 19%; hazard ratio [HR] = 2; 95% CI, 1.1–3.7; p = 0.02) and hospitalization (62.5% vs. 49.4%; HR = 1.6; 95% CI, 1.0–2.6; p = 0.03), respectively.

Practice Implications:

In the context of diagnosing and intervening, awareness of depressive symptoms dimensionality is crucial.

DOI

10.1111/ppc.12786

Access Rights

subscription content

Link to Full Text

Share

 
COinS